Back

CD300LG is a receptor for triglyceride-rich lipoproteins that facilitates postprandial lipid clearance

Granade, M. E.; Tveter, K. M.; Kim, H. I.; Yesian, A. R.; Fowler, J.; Ahn, Y.; Culver, J.; Tam Neale, K.; Amar, N.; Mazzocca, M.; White, A. R.; Archambault, D.; Sonavane, R.; Laforest, B.; Piper, M.; Roth Flach, R. J.; Rong, X.

2025-08-12 physiology
10.1101/2025.08.08.669356 bioRxiv
Show abstract

Circulating triglycerides are principally transported by triglyceride-rich lipoprotein particles (TRLs) including very-low-density-lipoproteins (VLDL) and chylomicrons and require the activity of lipoprotein lipase for appropriate lipid processing and cellular uptake. Despite known genetic links between CD300LG variants and altered lipid profiles, the functional role of CD300LG in lipid metabolism remains unclear. In this study, we identify CD300LG as a crucial receptor for TRLs. Human genetic analyses reveal that reduced CD300LG protein levels are causally linked with CAD risk and increased number, diameter, and TAG concentration of TRLs. In mice, CD300LG deficiency results in postprandial hypertriglyceridemia independent of changes in VLDL secretion, intestinal lipid absorption, or lipoprotein lipase activity. Mechanistically, CD300LG acts as a receptor for TRLs through a direct interaction with ApoA4 to facilitate TRL clearance at the microvascular endothelium. These findings elucidate new functions for both CD300LG and ApoA4 and advance our general understanding of triglyceride metabolism.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.